Login / Signup

Seroprevalence of varicella antibodies in adults without clinical history of disease.

Konrad Silva BücheleDanusa Ferreira CorreaMari TuyamaAlberto Dos Santos de LemosMarcellus Dias da CostaEmersom Cicilini MesquitaDaniel Marinho da CostaJosé Cerbino-NetoMargareth Catoia VarelaPedro Emmanuel Alvarenga Americano do BrasilLuciana Gomes Pedro Brandão
Published in: Cadernos de saude publica (2020)
Varicella in adults and immunocompromised patients can be severe. The clinical diagnosis of varicella has high accuracy and the history of disease has a high positive predictive value for protection. A significant portion of adults, however, cannot remember if they have had varicella, especially older individuals. We conducted a cross-sectional study to determine the seroprevalence of varicella protective antibodies titers in adults with no clinical history of disease, attended at a Reference Center for Special Immunobiologicals and Travel Medicine in Rio de Janeiro (Brazil). Titration of immunoglobulin G (IgG) antibodies to varicella-zoster was determined by chemiluminescence immunoassay. Among 140 adults without history of varicella, 92% had protective antibody titers. We concluded that seroprevalence of varicella-zoster protection was very high in adults with negative history of disease and the use of serology before vaccination reduced significantly unnecessary vaccine and immunoglobulin use.
Keyphrases
  • physical activity
  • ejection fraction
  • end stage renal disease
  • newly diagnosed
  • prognostic factors
  • sensitive detection
  • early onset
  • patient reported outcomes